286 related articles for article (PubMed ID: 8761597)
1. Usefulness of a computerized expert system associated with systematic O-serotyping for the early detection of outbreaks of hospital acquired infections and for the presumptive antibiotic therapy of Pseudomonas aeruginosa infections.
Watine J; Charet JC; Bruel A; Bouilloux JP; Palliez J
Pathol Biol (Paris); 1996 Feb; 44(2):125-31. PubMed ID: 8761597
[TBL] [Abstract][Full Text] [Related]
2. Susceptibility of multiresistant serotype 012 Pseudomonas aeruginosa to fosfomycin in combination with other antibiotics.
Watine J; Bourrel C; Dubourdieu B; Gineston JL; Bories P; Durand M; Marre A; Formosa F; Brunel MP; Palliez J
Pathol Biol (Paris); 1994 Apr; 42(4):293-5. PubMed ID: 7808781
[TBL] [Abstract][Full Text] [Related]
3. Pseudomonas aeruginosa infections in the Intensive Care Unit: can the adequacy of empirical beta-lactam antibiotic therapy be improved?
Bhat S; Fujitani S; Potoski BA; Capitano B; Linden PK; Shutt K; Paterson DL
Int J Antimicrob Agents; 2007 Nov; 30(5):458-62. PubMed ID: 17703923
[TBL] [Abstract][Full Text] [Related]
4. Analysis of resistance, cross-resistance and antimicrobial combinations for Pseudomonas aeruginosa isolates from 1997 to 2009.
Master RN; Clark RB; Karlowsky JA; Ramirez J; Bordon JM
Int J Antimicrob Agents; 2011 Oct; 38(4):291-5. PubMed ID: 21737249
[TBL] [Abstract][Full Text] [Related]
5. [Sensitivity to fosfomycin of multiresistant serotype 012 Pseudomonas aeruginosa. Multicenter study].
Dubrous P; Cavallo JD; Buisson Y
Pathol Biol (Paris); 1997 Jun; 45(6):472-8. PubMed ID: 9309262
[TBL] [Abstract][Full Text] [Related]
6. Clinical, microbiologic, and epidemiologic characteristics of Pseudomonas aeruginosa infections in a University Hospital, Malatya, Turkey.
Yetkin G; Otlu B; Cicek A; Kuzucu C; Durmaz R
Am J Infect Control; 2006 May; 34(4):188-92. PubMed ID: 16679175
[TBL] [Abstract][Full Text] [Related]
7. Investigation of a nosocomial outbreak by alginate-producing pan-antibiotic-resistant Pseudomonas aeruginosa.
Yakupogullari Y; Otlu B; Dogukan M; Gursoy C; Korkmaz E; Kizirgil A; Ozden M; Durmaz R
Am J Infect Control; 2008 Dec; 36(10):e13-8. PubMed ID: 19084158
[TBL] [Abstract][Full Text] [Related]
8. Antimicrobial therapy and control of multidrug-resistant Pseudomonas aeruginosa bacteremia in a teaching hospital in Taiwan.
Leung CH; Wang NY; Liu CP; Weng LC; Hsieh FC; Lee CM
J Microbiol Immunol Infect; 2008 Dec; 41(6):491-8. PubMed ID: 19255693
[TBL] [Abstract][Full Text] [Related]
9. [Pseudomonas aeruginosa: a multicenter study in 136 hospitals in Spain].
Bouza E; Garcia-Garrote F; Cercenado E; Marín M; Díaz MS; Sánchez Romero I; Vindel A;
Rev Esp Quimioter; 2003 Mar; 16(1):41-52. PubMed ID: 12750756
[TBL] [Abstract][Full Text] [Related]
10. [Is the a connection between prolonged carriage and clonal hospital-to-hospital clonal spread of multiresistant Pseudomonas aeruginosa of the O12 serotype? Are the specific habits of the hospitals involved the cause?].
Watine J; Hacini J; Vidal I
Pathol Biol (Paris); 1999 May; 47(5):457-61. PubMed ID: 10418018
[TBL] [Abstract][Full Text] [Related]
11. [Prevalence of serotype 0:12 among strains of P. aeruginosa causing nosocomial infection in Spain (1980-1991)].
Vindel A; Azañedo L; Trincado P; Martín-Bourgón C
Enferm Infecc Microbiol Clin; 1993 Jan; 11(1):29-32. PubMed ID: 8461369
[TBL] [Abstract][Full Text] [Related]
12. Nosocomial outbreak due to a multiresistant strain of Pseudomonas aeruginosa P12: efficacy of cefepime-amikacin therapy and analysis of beta-lactam resistance.
Dubois V; Arpin C; Melon M; Melon B; Andre C; Frigo C; Quentin C
J Clin Microbiol; 2001 Jun; 39(6):2072-8. PubMed ID: 11376037
[TBL] [Abstract][Full Text] [Related]
13. Antimicrobial susceptibility pattern of clinical isolates of Pseudomonas aeruginosa in a tertiary care hospital.
Raja NS; Singh NN
J Microbiol Immunol Infect; 2007 Feb; 40(1):45-9. PubMed ID: 17332906
[TBL] [Abstract][Full Text] [Related]
14. Nosocomial infections due to multidrug-resistant Pseudomonas aeruginosa: epidemiology and treatment options.
Obritsch MD; Fish DN; MacLaren R; Jung R
Pharmacotherapy; 2005 Oct; 25(10):1353-64. PubMed ID: 16185180
[TBL] [Abstract][Full Text] [Related]
15. Clinical surveillance of surgical imipenem-resistant Pseudomonas aeruginosa infection in a Japanese hospital.
Sasaki M; Hiyama E; Takesue Y; Kodaira M; Sueda T; Yokoyama T
J Hosp Infect; 2004 Feb; 56(2):111-8. PubMed ID: 15019222
[TBL] [Abstract][Full Text] [Related]
16. Occurrence of antipseudomonal beta-lactams and aminoglycosides resistance in Pseudomonas aeruginosa during therapy.
Pagani L; Scarabelli M; Cereda PM; Debiaggi M
Microbiologica; 1987 Jan; 10(1):103-10. PubMed ID: 3106759
[TBL] [Abstract][Full Text] [Related]
17. Treatment and control of severe infections caused by multiresistant Pseudomonas aeruginosa.
Rossolini GM; Mantengoli E
Clin Microbiol Infect; 2005 Jul; 11 Suppl 4():17-32. PubMed ID: 15953020
[TBL] [Abstract][Full Text] [Related]
18. Epidemiology and clinical outcomes of patients with multiresistant Pseudomonas aeruginosa.
Harris A; Torres-Viera C; Venkataraman L; DeGirolami P; Samore M; Carmeli Y
Clin Infect Dis; 1999 May; 28(5):1128-33. PubMed ID: 10452647
[TBL] [Abstract][Full Text] [Related]
19. [Hospital infections caused by Pseudomonas aeruginosa. Significance in intensive therapy].
Sidorenko SV; Gel'fand EB; Mamontova OA
Anesteziol Reanimatol; 1999; (3):46-54. PubMed ID: 10458038
[TBL] [Abstract][Full Text] [Related]
20. Nosocomial consequences of antibiotic usage.
Giamarellou H; Touliatou K; Koratzanis G; Petrikkos G; Kanellakopoulou K; Lelekis M; Pagona A; Tsagarakis J; Symeonides J; Falagas M
Scand J Infect Dis Suppl; 1986; 49():182-8. PubMed ID: 3103210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
